"use strict";(self.webpackChunkmy_website=self.webpackChunkmy_website||[]).push([[1237],{3905:(e,t,a)=>{a.d(t,{Zo:()=>p,kt:()=>f});var i=a(7294);function n(e,t,a){return t in e?Object.defineProperty(e,t,{value:a,enumerable:!0,configurable:!0,writable:!0}):e[t]=a,e}function r(e,t){var a=Object.keys(e);if(Object.getOwnPropertySymbols){var i=Object.getOwnPropertySymbols(e);t&&(i=i.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),a.push.apply(a,i)}return a}function o(e){for(var t=1;t<arguments.length;t++){var a=null!=arguments[t]?arguments[t]:{};t%2?r(Object(a),!0).forEach((function(t){n(e,t,a[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(a)):r(Object(a)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(a,t))}))}return e}function s(e,t){if(null==e)return{};var a,i,n=function(e,t){if(null==e)return{};var a,i,n={},r=Object.keys(e);for(i=0;i<r.length;i++)a=r[i],t.indexOf(a)>=0||(n[a]=e[a]);return n}(e,t);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);for(i=0;i<r.length;i++)a=r[i],t.indexOf(a)>=0||Object.prototype.propertyIsEnumerable.call(e,a)&&(n[a]=e[a])}return n}var l=i.createContext({}),c=function(e){var t=i.useContext(l),a=t;return e&&(a="function"==typeof e?e(t):o(o({},t),e)),a},p=function(e){var t=c(e.components);return i.createElement(l.Provider,{value:t},e.children)},u="mdxType",h={inlineCode:"code",wrapper:function(e){var t=e.children;return i.createElement(i.Fragment,{},t)}},m=i.forwardRef((function(e,t){var a=e.components,n=e.mdxType,r=e.originalType,l=e.parentName,p=s(e,["components","mdxType","originalType","parentName"]),u=c(a),m=n,f=u["".concat(l,".").concat(m)]||u[m]||h[m]||r;return a?i.createElement(f,o(o({ref:t},p),{},{components:a})):i.createElement(f,o({ref:t},p))}));function f(e,t){var a=arguments,n=t&&t.mdxType;if("string"==typeof e||n){var r=a.length,o=new Array(r);o[0]=m;var s={};for(var l in t)hasOwnProperty.call(t,l)&&(s[l]=t[l]);s.originalType=e,s[u]="string"==typeof e?e:n,o[1]=s;for(var c=2;c<r;c++)o[c]=a[c];return i.createElement.apply(null,o)}return i.createElement.apply(null,a)}m.displayName="MDXCreateElement"},6953:(e,t,a)=>{a.r(t),a.d(t,{assets:()=>l,contentTitle:()=>o,default:()=>h,frontMatter:()=>r,metadata:()=>s,toc:()=>c});var i=a(7462),n=(a(7294),a(3905));const r={},o="Penelope",s={unversionedId:"penelope/penelope",id:"penelope/penelope",title:"Penelope",description:"Intrahepatic Cholestasis of Pregnancy(ICP)",source:"@site/../../family/penelope/penelope.md",sourceDirName:"penelope",slug:"/penelope/",permalink:"/family/penelope/",draft:!1,editUrl:"https://github.com/facebook/docusaurus/tree/main/packages/create-docusaurus/templates/shared/../../family/penelope/penelope.md",tags:[],version:"current",lastUpdatedBy:"liviaerxin",lastUpdatedAt:1686232686,formattedLastUpdatedAt:"Jun 8, 2023",frontMatter:{},sidebar:"tutorialSidebar",previous:{title:"Index",permalink:"/family/"},next:{title:"zeno",permalink:"/family/penelope/zeno"}},l={},c=[{value:"Intrahepatic Cholestasis of Pregnancy(ICP)",id:"intrahepatic-cholestasis-of-pregnancyicp",level:2},{value:"Clinical and biochemical symptoms of ICP",id:"clinical-and-biochemical-symptoms-of-icp",level:3},{value:"Stillbirth rate of ICP",id:"stillbirth-rate-of-icp",level:3},{value:"Clinical Approach to ICP",id:"clinical-approach-to-icp",level:3},{value:"Obstetric Cholestasis(OC)",id:"obstetric-cholestasisoc",level:2},{value:"OC Diagnosis",id:"oc-diagnosis",level:2}],p={toc:c},u="wrapper";function h(e){let{components:t,...r}=e;return(0,n.kt)(u,(0,i.Z)({},p,r,{components:t,mdxType:"MDXLayout"}),(0,n.kt)("h1",{id:"penelope"},"Penelope"),(0,n.kt)("h2",{id:"intrahepatic-cholestasis-of-pregnancyicp"},"Intrahepatic Cholestasis of Pregnancy(ICP)"),(0,n.kt)("ul",null,(0,n.kt)("li",{parentName:"ul"},"TBA(Total Bile Acid)"),(0,n.kt)("li",{parentName:"ul"},"ICP(Intrahepatic Cholestasis in Pregnancy)")),(0,n.kt)("p",null,(0,n.kt)("a",{parentName:"p",href:"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290322/"},"Intrahepatic Cholestasis in Pregnancy: Review of the Literature")),(0,n.kt)("h3",{id:"clinical-and-biochemical-symptoms-of-icp"},"Clinical and biochemical symptoms of ICP"),(0,n.kt)("ul",null,(0,n.kt)("li",{parentName:"ul"},"pruritus"),(0,n.kt)("li",{parentName:"ul"},"progressive increased levels of total bile acids (TBA)")),(0,n.kt)("p",null,"severe ICP:"),(0,n.kt)("ul",null,(0,n.kt)("li",{parentName:"ul"},"pruritus"),(0,n.kt)("li",{parentName:"ul"},"TBA > 40 \u03bcmol/L")),(0,n.kt)("h3",{id:"stillbirth-rate-of-icp"},"Stillbirth rate of ICP"),(0,n.kt)("p",null,"Ovadia et al. found that for singleton pregnancies, the prevalence of stillbirth was three (0.13%) of 2310 intrahepatic cholestasis of pregnancy cases in women with serum total bile acids of less than 40 \u03bcmol/L versus four (0.28%) of 1412 cases with total bile acids of 40\u201399 \u03bcmol/L and versus 18 (3.44%) of 524 cases for bile acids of 100 \u03bcmol/L or more ","[24]",".Germain et al. observed that bile acids increase the expression and sensitivity of oxytocin receptors in uterine muscles, potentially leading to increased rates of premature deliveries in ICP patients ","[25]","."),(0,n.kt)("h3",{id:"clinical-approach-to-icp"},"Clinical Approach to ICP"),(0,n.kt)("p",null,(0,n.kt)("a",{parentName:"p",href:"https://www.researchgate.net/publication/235380677_A_Clinical_Approach_to_Intrahepatic_Cholestasis_of_Pregnancy"},"A Clinical Approach to Intrahepatic Cholestasis of Pregnancy")),(0,n.kt)("p",null,(0,n.kt)("img",{alt:"Suggested-management-algorithm-for-ICP-If-TBA-levels-continue-to-rise-or-minor-response",src:a(2541).Z,width:"850",height:"963"})),(0,n.kt)("h2",{id:"obstetric-cholestasisoc"},"Obstetric Cholestasis(OC)"),(0,n.kt)("p",null,(0,n.kt)("a",{parentName:"p",href:"https://www.rcog.org.uk/for-the-public/browse-all-patient-information-leaflets/obstetric-cholestasis-patient-information-page/"},"Obstetric Cholestasis")),(0,n.kt)("p",null,"some ",(0,n.kt)("strong",{parentName:"p"},"gists:")),(0,n.kt)("blockquote",null,(0,n.kt)("p",{parentName:"blockquote"},"Recent research has shown that the risk of stillbirth is the same as in women without obstetric cholestasis (1 in 200)")),(0,n.kt)("p",null,(0,n.kt)("a",{parentName:"p",href:"https://www.tommys.org/pregnancy-information/pregnancy-complications/obstetric-cholestasis"},"Obstetric Cholestasis")),(0,n.kt)("blockquote",null,(0,n.kt)("p",{parentName:"blockquote"},"Obstetric Cholestasis = ICP\nBut recent research suggests that the risk of stillbirth is increased in women with intrahepatic cholestasis of pregnancy carrying 1 baby when bile acids are 100 \u03bcmol/L or more. It may be reassuring to hear that most women with ICP have bile acids below this number, so their risk of a stillbirth is similar to that of pregnant women in the general population.")),(0,n.kt)("h2",{id:"oc-diagnosis"},"OC Diagnosis"),(0,n.kt)("p",null,(0,n.kt)("a",{parentName:"p",href:"https://mft.nhs.uk/app/uploads/sites/4/2018/07/Cholestasis.pdf"},"Obstetric Cholestasis (OC) diagnosis and management guideline")),(0,n.kt)("p",null,"Mild Obstetric Cholestasis: bile acids > 14mmol/L\nModerate Obstetric Cholestasis: bile acids > 40mmol/L\nSevere Obstetric Cholestasis: bile acids > 100mmol/L\nIncreasing fetal risks are directly associated with increasing maternal\nserum bile acids (Glantz et al, 2004)."))}h.isMDXComponent=!0},2541:(e,t,a)=>{a.d(t,{Z:()=>i});const i=a.p+"assets/images/Suggested-management-algorithm-for-ICP-If-TBA-levels-continue-to-rise-or-minor-response-23b3050935468820c512482fca87cf76.png"}}]);